Tiziana Life Sciences PLC (TILST)

58.50
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    58.50 - 58.60

TILST Overview

Prev. Close
54
Day's Range
58.5-58.6
Revenue
-
Open
55.5
52 wk Range
45-195
EPS
-0.17
Volume
0
Market Cap
56.92M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
242,403
P/E Ratio
-
Beta
-1.32
1-Year Change
-61.51%
Shares Outstanding
97,306,145
Next Earnings Date
07 Jun 2022
What is your sentiment on Tiziana Life Sciences PLC?
or
Vote to see community's results!

Tiziana Life Sciences PLC Company Profile

Employees
11

Tiziana Life Sciences Ltd is a clinical stage biotechnology company. The Company is focused on the discovery and development of molecules and related diagnostics to treat unmet medical needs in oncology and immunology. Its lead product candidates include Foralumab (TZLS-401), Anti IL-6R mAb (TZLS-501), and Milciclib TZLS-201. Foralumab (TZLS-401) is a fully human engineered anti-human cluster of differentiation 3 (CD3) monoclonal antibody (mAb). Foralumab is developed for the treatment of neurodegenerative diseases such as progressive Multiple Sclerosis (MS), and Crohn’s disease. The Anti IL-6R mAb (TZLS-501) is a fully human engineered mAb targeting the interleukin-6 receptor (IL-6R). Anti-IL-6R antibody can be used in combination with Foralumab or other anti-inflammatory and anti-infective agents as therapy for COVID-19 and oncology indications. The Company has developed Milciclib TZLS-201 for the treatment of hepatocellular carcinoma (HCC).

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
  • The ships sinking and the uk holders cant sell and dump this pile of POO.
    0
    • thank god i sold out!
      0
      • Such strength in the US listing recently, momentum in price is starting in the UK folks...
        0
        • Its think its a prudent move buddy, I too am building a position here now.
          0
          • back in the game
            0
            • Its think its a prudent move buddy, I too am building a position here now.
              1
          • fingers crossed for the brazil results
            0
            • Sold all today, good luck to others still holding
              4
              • Ready for takeoff!
                0
                • Exited partially with big gains, will keep the other half for long term
                  1
                  • Trading Volume of 3x times of average suggest very positive momentum. FTSE 250 listing, very encouraging trial results and Dr Neil Graham from Regeneron Pharmaceuticals joining TILS are all very positive developments
                    1
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.